Anthera, Endologix Fall into Wednesday’s 52-Week Low Club
December 28, 2016: Here are four stocks trading with relatively heavy volume among 59 equities making new 52-week lows in Wednesday’s session. On the NYSE, decliners led advancers by nearly 3 to 1 and on the Nasdaq decliners led advancers…
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
December 28, 2016: Here are four stocks trading with relatively heavy volume among 59 equities making new 52-week lows in Wednesday’s session. On the NYSE, decliners led advancers by nearly 3 to 1 and on the Nasdaq decliners led advancers by about the same margin. Total volume reached about three-quarters of the daily average.
Anthera Pharmaceuticals Inc. (NASDAQ: ANTH) dropped about 67% on Wednesday to post a new 52-week low of $0.67 after closing at $2.01 on Tuesday. The stock’s 52-week high is $32.83. Volume of more than 15 million shares was about 15 times the daily average of about 1 million. The drug maker did not meet its expected targets in a phase III study.
Endologix Inc. (NASDAQ: ELGX) dropped about 9.3% on Wednesday to post a new 52-week low of $4.78 against a 52-week high of $14.50 and a Tuesday close of $5.27. Volume of about 6 million was more than 3 times the daily average of around 1.7 million. The company on Tuesday announced a temporary shipping hold on its best-selling heart device, saying there was a manufacturing issue.
Hanesbrands Inc. (NYSE: HBI) dropped about 1.2% on Wednesday to post a new 52-week low of $21.44 after closing at $21.70 on Tuesday. The stock’s 52-week high is $31.36. Volume was about half the daily average of around 2.6 million shares. The company had no specific news Wednesday.
Kimco Realty Corp. (NYSE: KIM) dropped about 1.7% Wednesday to post a new 52-week low of $24.63 after closing Tuesday at $25.04. The 52-week high is $32.24. Volume of around 2.4 million was about 40% below the daily average of around 3.9 million shares traded. The company had no specific news.
Contact [email protected] for any questions or corrections.